Navigation Links
Antipsychotics Best for Controlling Mania: Study
Date:8/17/2011

By Maureen Salamon
HealthDay Reporter

TUESDAY, Aug. 16 (HealthDay News) -- The manic episodes experienced by those with bipolar disorder are better controlled by antipsychotic drugs than mood stabilizers, a new, large study suggests.

Researchers from Italy and the United Kingdom also found that three antipsychotics -- first-generation haloperidol (Haldol) along with later formulations of risperidone (Risperdal) and olanzapine (Zyprexa) -- outperformed 11 other drugs. The scientists analyzed results from 68 randomized, controlled trials with more than 16,000 participants over a 30-year period.

Mania typically alternates with depression in those with bipolar disorder, which tends to run in families and begin between the ages of 15 and 25, according to the U.S. National Institutes of Health. Acute manic episodes -- characterized by hyperactivity, racing thoughts and reckless behavior -- are not experienced by all bipolar patients, but severe symptoms often require hospitalization, health officials said.

Broadly defined as an "excessively raised mood," mania affects about 1 percent of the population, according to the study authors.

"The most important point is that this is a study about acute treatment of manic episodes, not long-term management or prevention," said Dr. Gregory Simon, a psychiatrist and mental health researcher at Group Health Cooperative in Seattle, who was not involved in the study. "The idea that antipsychotic treatments are good for manic episodes is well-known, but the finding that one of the older ones is better is newsworthy here."

Antipsychotics and other drugs commonly used to treat mania are known to have many significant side effects, which can sometimes disrupt treatment. Study co-author Dr. Andrea Cipriani, a lecturer in psychiatry at the University of Verona in Italy, said haloperidol and risperidone are more likely than olanzapine to cause movement problems such as tremors and rigidity, while olanzapine is linked to higher rates of weight gain, metabolic syndrome and diabetes. Some antipsychotic medications may cause irregular heartbeat as well.

Cipriani said the new research was the first of its type to compare anti-manic drugs -- including antipsychotics, anticonvulsants and lithium -- and rank them according to their effectiveness and ability to be tolerated. She and her colleagues completed a similar study on antidepressants several years ago.

In head-to-head comparisons among drugs, the study authors found that haloperidol was more effective than aripiprazole, asenapine, carbamazepine, valproate, gabapentin, lamotrigine, lithium, quetiapine, topiramate and ziprasidone. Risperidone, olanzapine and quetiapine were most likely to be tolerated by patients and outperformed lithium, lamotrigine, topiramate and gabapentin.

The new research, which was not funded by the pharmaceutical industry, appears in the Aug. 17 online edition of The Lancet.

"Psychiatrists now have an evidence-based hierarchy when they are to prescribe an anti-manic agent for acute mania," Cipriani said. "These findings are in line with what psychiatrists usually prescribe in their daily practice. There are new treatments that have been recently marketed for acute mania, but this study shows that clinicians should be aware these new compounds are not better -- and may be worse -- than older ones, and these [new] drugs are much more expensive."

Long-term management of bipolar disorder usually requires a combination of medications, Cipriani and Simon said, and antipsychotics typically are used for extreme manic episodes for only several weeks at a time.

In a commentary accompanying the study, Australian researchers Dr. Michael Berk, chair of psychiatry at the Deakin University School of Medicine, and Gin S. Malhi, with the department of psychiatry at Royal North Shore Hospital in Sydney, said it's useful to know that haloperidol seems to be a top-line treatment for the treatment of acute mania.

But, they added, haloperidol "lacks maintenance efficacy for depression -- the predominant clinical state [of patients with bipolar disorder] -- and indeed carries an inherent risk of incident depression."

More information

To learn more about bipolar disorder and its treatment, visit the U.S. National Institute of Mental Health.

SOURCES: Andrea Cipriani, M.D., Ph.D., lecturer in psychiatry, University of Verona, Italy; Gregory Simon, M.D., M.P.H., psychiatrist and mental health researcher, Group Health Cooperative, Seattle; Aug. 17, 2011, The Lancet, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Atypical Antipsychotics Linked to Blood Clot Risk in Study
2. Parkinsons Patients Still Prescribed Antipsychotics Despite Warning
3. Patients Taking Antipsychotics Urged to Get Routine Physicals
4. Health Secretary Encourages Pennsylvanians to Learn the ABCs of Controlling Diabetes
5. Controlling symptoms can lead to improved quality of life for end-of-life patients
6. Controlling the rising costs of cardiovascular care
7. New clue to controlling skin regeneration -- as well as skin cancer
8. UC Davis pain research may pave the way to understanding and controlling chronic pain
9. Avoiding or controlling diabetes may reduce cancer risk and mortality
10. For Young Women, Controlling Partner Often Abusive, Too
11. Studies Highlight Challenge of Controlling Resistant Bacteria in Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Antipsychotics Best for Controlling Mania: Study
(Date:6/23/2017)... ... June 23, 2017 , ... ... personal financial planning to families and business owners in North Central West Virginia, ... help provide services to differently abled residents in the region. , The Stepping ...
(Date:6/22/2017)... , ... June 22, 2017 , ... Plastic Surgery Associates ... a Top Doctor for 2017. Each year, research and information firm, Castle Connolly, releases ... the title in 2015, this marks the 3rd time that Dr. Canales ...
(Date:6/22/2017)... Washington, DC (PRWEB) , ... June 22, 2017 ... ... awarded a $3.7 million grant from the American Heart Association (AHA) to launch ... economic incentives to improve the prevention and diagnosis of rheumatic heart disease (RHD) ...
(Date:6/22/2017)... ... 22, 2017 , ... Vighter, a premier provider of Unconventional ... ANSI/ASIS PSC.1-2012. The company’s work in countries throughout Southwest Asia, South America, and ... been degraded. The PSC.1 standard was created to protect fundamental freedoms and human ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, a ... Nashville-based private equity firm, has invested $3.35 million in the company. , ... Claritas Capital offers the smart money, speed to market and accountability we had ...
Breaking Medicine News(10 mins):
(Date:6/10/2017)... Ala. , June 9, 2017  Shane K. Burchfield, DPM, ... recognized for excellence as a Podiatrist in Alabama ... Podiatry at Family First Foot Care. He brings over 20 years ... medicine, pain management and healthcare, to his role. ... First Foot Care, PC is pleased to welcome you ...
(Date:6/8/2017)... June 8, 2017  Less than a month ago, ... than 200,000 companies, including hospital networks, in over 150 ... one of the largest online extortion attempts ever recorded. ... market, it is imperative that providers understand where the ... from this — and many other very real cyber ...
(Date:6/7/2017)... June 7, 2017 Endo International plc (NASDAQ: ... 2017, the Hon. Joseph R. Goodwin , U.S. ... West Virginia , entered a case management ... Repair System Products Liability Litigation (the "MDL") that includes ... to provide expert disclosures on specific causation within one ...
Breaking Medicine Technology: